Research underway at the Trudeau Institute could lead to new treatments for people sickened by Listeria and other sepsis-causing bacteria. Dr. Stephen Smiley's laboratory has published a study in the scientific journal Infection and Immunity that supports a new approach to treating these infections.
Listeria can cause serious illness, especially among the elderly, the very young and those with compromised immune systems. The bacteria can also cause significant complications in pregnant women, including miscarriage.
The CDC is reporting that one miscarriage and 23 deaths can be attributed to a recent outbreak of Listeria infections in the United States caused by tainted cantaloupes; 116 persons from 25 states have been infected with the outbreak-associated strains.
Ingestion of Listeria usually causes a limited gastrointestinal illness; however, the bacteria sometimes spread to other parts of the body, resulting in a deadly sepsis. Despite decades of medical research, severe infections caused by Listeria and other bacteria that cause sepsis, like MRSA, still threaten human health.
The Trudeau Institute study demonstrates that mice that have been genetically modified so they cannot produce factor XI (FXI), a specific blood-clotting factor, have an improved capacity to withstand injection with high doses of Listeria. The study also shows that normal mice treated with both an antibody targeting FXI along with antibiotics show improved survival during septic Listeria infection, as compared with mice treated with antibiotics alone.
These findings suggest FXI-targeted therapeutics may be useful for treating severe infections caused by Listeria and other sepsis-causing bacteria.
This recent work builds on a long history of Listeria research at the Trudeau Institute. In the 1960s the Institute's first director, Dr. George B. Mackaness, advanced the use of mouse models to study how cells of the immune system combat Listeria. He discovered that activated macrophages play a critical role in killing Listeria. He also discovered that lymphocytes, another type of immune cell, orchestrate this killing response. These seminal observations remain the foundation for modern studies of cell-mediated defense against pathogens.
The Trudeau Institute's second director, Dr. Robert J. North, extended this work by identifying the key subset of anti-Listeria lymphocytes: T cells. Dr. North and his Trudeau colleagues also described crucial roles for NK cells and neutrophils.
Several years ago, Dr. Smiley discovered that blood-clotting proteins also play critical protective roles during immune defense against Listeria. "I was really intrigued by our finding that clotting protects against Listeria because so many other studies had shown that clotting clogs blood vessels and contributes to organ failure and death during septic infections," said Dr. Smiley.
"Our finding suggested that some degree of blood clotting is essential for effective immune defense, but too much is harmful. We set out in search of ways to prevent the bad clotting while maintaining the good."
Specifically, Dr. Smiley's lab looked for clotting factors that appeared to be hyperactive in the septic state.
"The paper we've just published is our first demonstration of this exciting new approach to treating sepsis – we found that FXI is overproduced during septic Listeria infections and that therapeutics targeting FXI can reduce septic disease while maintaining immune defense."
Postdoctoral fellow Deyan Luo, assisted by Frank Szaba and Larry Kummer, led the research in the Smiley lab. Dr. Lawrence Johnson from the Trudeau Institute, Dr. David Gailani from Vanderbilt University, and Drs. Andras Gruber and Erik Tucker from the Oregon Health & Science University also made essential contributions.
About the Trudeau Institute
The Trudeau Institute is an independent, not-for-profit, biomedical research organization, whose scientific mission is to make breakthrough discoveries leading to improved human health. Trudeau researchers are identifying the basic mechanisms used by the immune system to combat viruses like influenza, mycobacteria, such as tuberculosis, parasites and cancer, so that better vaccines and therapies can be developed for fighting deadly disease.
The research is supported by government grants and philanthropic contributions.
Kim Godreau | EurekAlert!
Navigational view of the brain thanks to powerful X-rays
18.10.2017 | Georgia Institute of Technology
Separating methane and CO2 will become more efficient
18.10.2017 | KU Leuven
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...
Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.
It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...
17.10.2017 | Event News
10.10.2017 | Event News
10.10.2017 | Event News
18.10.2017 | Physics and Astronomy
18.10.2017 | Physics and Astronomy
18.10.2017 | Life Sciences